Filing Details
- Accession Number:
- 0001627223-20-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 12:39:53
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-21 12:39:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1627223 | Chemours Co | CC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1474107 | P Mark Vergnano | 1007 Market Street Wilmington DE 19801 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-18 | 153,392 | $15.49 | 395,745 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-18 | 153,392 | $27.28 | 242,353 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-18 | 153,392 | $0.00 | 153,392 | $15.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 512,076 | Indirect | By GRAT |
Footnotes
- The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan.
- Price reported is an average. Shares were sold in multiple transactions at prices ranging from $26.79 to $27.87.
- These options were issued to the reporting person while he was employed by DuPont and were converted to Chemours options in connection with the Company's separation from DuPont.